… plus Fuzheng Kang'ai Formula (扶正抗癌方) in patients with advanced non-small cell lung cancer with epidermal growth factor receptor mutation: a randomized …
X Yang, X Chai, W Wu, S Long, H Deng, Z Pan… - Chinese journal of …, 2018 - Springer
… been used as complementary and alternative therapy for cancer … gefitinib with platinumbased
chemotherapy as first-line treatment … Randomized phase Ⅱ study of erlotinib plus tivantinib …
chemotherapy as first-line treatment … Randomized phase Ⅱ study of erlotinib plus tivantinib …
头颈部鳞状细胞癌的靶向治疗研究进展
吴静， 刘业海 - 山东大学耳鼻喉眼学报, 2018 - ebhyxbwk.njournal.sdu.edu.cn
… with locally-advanced larynx cancer and who respond to induction chemotherapy? An
organ preservation TTCC phase II study[J]. Int J Radiat Oncol Biol Phys, 2017, 97(3):473-480. …
organ preservation TTCC phase II study[J]. Int J Radiat Oncol Biol Phys, 2017, 97(3):473-480. …
EGFR 敏感突变的晚期肺腺癌一线化疗与吉非替尼联合治疗的随机对照研究
金波， 张岩巍， 韩宝惠 - 中国癌症杂志, 2015 - china-oncology.com
… efficacy and safety of gefitinib plus chemotherapy with gefitinib or chemotherapy alone
for … A randomised phase Ⅱ study of pemetrexed versus pemetrexed+erlotinib as second-line …
for … A randomised phase Ⅱ study of pemetrexed versus pemetrexed+erlotinib as second-line …
[HTML][HTML] FOLFIRINOX 对比吉西他滨治疗晚期胰腺癌
T Conroy, F Desseigne, M Ychou, O Bouché… - jiaowen.net
… Six months of chemotherapy were recommended in both … Ac-cordingly, we conducted a phase
2 study of the … the combination of erlotinib and gemcitabine as compared with gemcitabine …
2 study of the … the combination of erlotinib and gemcitabine as compared with gemcitabine …
[HTML][HTML] EGFR 敏感突变NSCLC 患者的最佳治疗模式探讨
史钟， 范云 - Chinese Journal of Lung Cancer, 2015 - ncbi.nlm.nih.gov
… Rrandomized phase Ⅲ trials comparing EGFR-TKI with chemotherapy as the first-line …
Randomized phase Ⅱ trial of erlotinib alone or with carboplatin and paclitaxel in patients who …
Randomized phase Ⅱ trial of erlotinib alone or with carboplatin and paclitaxel in patients who …
表皮生长因子受体靶向药物对进展期胰腺癌治疗作用的Meta 分析.
周子栋， 李仁礼， 陈凯， 张文成… - Journal of Clinical …, 2020 - search.ebscohost.com
… Erlotinib plus gemcitabine compared with gemcitabine … compared with gemcitabine and
cisplatin alone in patients with advanced pancreatic cancer: A randomised, multicentre, phase II …
cisplatin alone in patients with advanced pancreatic cancer: A randomised, multicentre, phase II …
[PDF][PDF] 厄洛替尼治疗晚期非小细胞肺癌的系统评价
朱利娜， 杨振君， 王士勇， 汤燕明 - 中国肺癌杂志, 2009 - scholar.archive.org
… The aim of this study is to review the effectiveness and safety of erlotinib for treating advanced
… from erlotinib combined chemotherapy remains uncertain. But the effect of erlotinib being …
… from erlotinib combined chemotherapy remains uncertain. But the effect of erlotinib being …
[HTML][HTML] 分子靶向药物应用于非小细胞肺癌维持治疗的研究进展
单利 - Chinese Journal of Lung Cancer, 2010 - ncbi.nlm.nih.gov
… Updated analysis of SWOG 0023: A randomized phase Ⅲ trial of gefitinib versus placebo …
: A phase Ⅱ randomized doubleblind trial of sequential erlotinib and chemotherapy as first-…
: A phase Ⅱ randomized doubleblind trial of sequential erlotinib and chemotherapy as first-…
[HTML][HTML] 非小细胞肺癌脑转移治疗进展
林根， 徐海鹏， 黄诚 - Chinese Journal of Lung Cancer, 2014 - ncbi.nlm.nih.gov
… single arm phase Ⅱ … single arm phase Ⅱ … NCT01578668 Prospective single arm
phase Ⅱ Erlotinib+chemotherapy (pemetrexed plus carboplatin) Adenocarcinoma …
phase Ⅱ Erlotinib+chemotherapy (pemetrexed plus carboplatin) Adenocarcinoma …
非小细胞肺癌术后辅助治疗的几个热点
李倩， 王哲海 - 循证医学, 2013 - jebm.cn
… The EGFR tyrosine kinase inhibitors, Gefitinib (Iressa) and Erlotinib (Tarceva), are two …
Randomized study of adjuvant chemotherapy for completely resected stage Ⅰ, Ⅱ or ⅢA …
Randomized study of adjuvant chemotherapy for completely resected stage Ⅰ, Ⅱ or ⅢA …